Detalles de la búsqueda
1.
Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy and Docetaxel in Black Patients From the Randomized ARASENS Trial.
Oncologist
; 29(3): 235-243, 2024 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37812679
2.
Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer.
N Engl J Med
; 385(12): 1091-1103, 2021 09 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34161051
3.
Efficacy and safety of darolutamide in Black/African-American patients from the phase III ARAMIS study.
Future Oncol
; 18(40): 4473-4482, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36753353
4.
CD8+ T Cells Impact Rising PSA in Biochemically Relapsed Cancer Patients Using Immunotherapy Targeting Tumor-Associated Antigens.
Mol Ther
; 28(5): 1238-1250, 2020 05 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32208168
5.
Re-treatment with radium-223: 2-year follow-up from an international, open-label, phase 1/2 study in patients with castration-resistant prostate cancer and bone metastases.
Prostate
; 79(14): 1683-1691, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31442327
6.
Real-world outcomes of sipuleucel-T treatment in PROCEED, a prospective registry of men with metastatic castration-resistant prostate cancer.
Cancer
; 125(23): 4172-4180, 2019 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31483485
7.
Clinical Correlates of Benefit From Radium-223 Therapy in Metastatic Castration Resistant Prostate Cancer.
Prostate
; 77(5): 479-488, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27990667
8.
Reply to Potential underestimation of cerebrovascular events in the PROVENGE Registry for the Observation, Collection, and Evaluation of Experience Data.
Cancer
; 126(12): 2935-2937, 2020 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32154908
9.
Deep and Durable Prostate-specific Antigen Response to Darolutamide with Androgen Deprivation Therapy and Docetaxel, and Association with Clinical Outcomes for Patients with High- or Low-volume Metastatic Hormone-sensitive Prostate Cancer: Analyses of the Randomized Phase 3 ARASENS Study.
Eur Urol
; 2024 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38644146
10.
Pembrolizumab plus Olaparib in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort A Study.
Eur Urol
; 83(1): 15-26, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36055895
11.
First-in-human, phase 1 study of PF-06753512, a vaccine-based immunotherapy regimen (VBIR), in non-metastatic hormone-sensitive biochemical recurrence and metastatic castration-resistant prostate cancer (mCRPC).
J Immunother Cancer
; 11(3)2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36948505
12.
177Lu-Prostate-Specific Membrane Antigen Ligand After 223Ra Treatment in Men with Bone-Metastatic Castration-Resistant Prostate Cancer: Real-World Clinical Experience.
J Nucl Med
; 63(3): 410-414, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34168015
13.
Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy.
Eur Urol Open Sci
; 34: 70-78, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34934969
14.
Phase I Study of Seviteronel, a Selective CYP17 Lyase and Androgen Receptor Inhibitor, in Men with Castration-Resistant Prostate Cancer.
Clin Cancer Res
; 24(21): 5225-5232, 2018 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30012563
15.
eRADicAte: A Prospective Evaluation Combining Radium-223 Dichloride and Abiraterone Acetate Plus Prednisone in Patients With Castration-Resistant Prostate Cancer.
Clin Genitourin Cancer
; 16(2): 149-154, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29196208
16.
Corrigendum to "Pembrolizumab plus Olaparib in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort A Study" [Eur Urol 83 (2023) 15-26].
Eur Urol
; 83(3): e87, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36528479
17.
Rapid androgen cycling as treatment for patients with prostate cancer.
Clin Cancer Res
; 12(24): 7414-21, 2006 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17189414
18.
Second-Line Hormonal Therapy for Men With Chemotherapy-Naïve, Castration-Resistant Prostate Cancer: American Society of Clinical Oncology Provisional Clinical Opinion.
J Clin Oncol
; 35(17): 1952-1964, 2017 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28441112
19.
Androgen Receptor Modulation Optimized for Response (ARMOR) Phase I and II Studies: Galeterone for the Treatment of Castration-Resistant Prostate Cancer.
Clin Cancer Res
; 22(6): 1356-63, 2016 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26527750
20.
[American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer].
Zhongguo Fei Ai Za Zhi
; 13(3): 171-89, 2010 Mar.
Artículo
en Zh
| MEDLINE | ID: mdl-20681066